1. Home
  2. GNLN vs PFSA Comparison

GNLN vs PFSA Comparison

Compare GNLN & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$2.10

Market Cap

1.5M

ML Signal

HOLD

PFSA

Profusa Inc.

HOLD

Current Price

$1.71

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
PFSA
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
GNLN
PFSA
Price
$2.10
$1.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.9K
1.0M
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
21.57
N/A
EPS
N/A
N/A
Revenue
$13,275,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.05
52 Week High
$7.06
$4.22

Technical Indicators

Market Signals
Indicator
GNLN
PFSA
Relative Strength Index (RSI) 34.17 56.07
Support Level $1.50 $0.21
Resistance Level $3.51 $2.25
Average True Range (ATR) 0.14 0.34
MACD 0.00 -0.04
Stochastic Oscillator 11.32 2.13

Price Performance

Historical Comparison
GNLN
PFSA

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). It serves specialty retailers, smoke shops, head shops, convenience stores, and consumers. Geographically, it operates in United States, Canada, and Europe. It derives majority revenue from the United States. Its two operating segments are: Wholesale and Distribution, which includes legacy e-commerce and drop-ship operations; and Digital Assets, which includes digital asset treasury activities including acquisition, staking and validator participation related to BERA.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: